theophylline has been researched along with clofibrate in 22 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 10 (45.45) | 18.7374 |
1990's | 1 (4.55) | 18.2507 |
2000's | 2 (9.09) | 29.6817 |
2010's | 9 (40.91) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Campillo, NE; Guerra, A; Páez, JA | 1 |
García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Raheja, KL; Tepperman, HM; Tepperman, J | 1 |
Ditschuneit, H; Ditschuneit, HH; Fussgänger, R | 1 |
Carlson, LA | 1 |
Blaton, V; Ferenczi, M; Lambelin, G; Peeters, H; Roba, J; Roncucci, R; Vandamme, D | 1 |
Diamantini, G; Duranti, E; Pescador, R; Salvatori, A; Spadoni, G | 1 |
Crepaldi, G; Jemmolo, RM; Lirussi, F; Muraca, M; Nassuato, G; Okolicsanyi, L; Orlando, R; Strazzabosco, M | 1 |
Bachmann, KA; Jahn, D; Schwartz, J; Yang, C | 1 |
Mendoza, SA; Tarpey, GM | 1 |
Farkas, K; Kusztos, D; Németh-Csóka, M; Pados, G; Valyon, M | 1 |
Djaja, S; Machalke, K; Richter, E | 1 |
Da Re, P; Gaion, RM; Montanari, P; Valenti, P | 1 |
2 review(s) available for theophylline and clofibrate
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
The effect of drugs on bile flow and composition. An overview.
Topics: Animals; Bile; Bile Acids and Salts; Cats; Chlorpromazine; Cholagogues and Choleretics; Cholesterol; Clofibrate; Colchicine; Cricetinae; Dehydrocholic Acid; Diuretics; Dogs; Enterohepatic Circulation; Estrogens; Glucagon; Guinea Pigs; Humans; Insulin; Liver; Macaca mulatta; Phospholipids; Rabbits; Rats; Rifampin; Rifamycins; Somatostatin; Theophylline; Ursodeoxycholic Acid | 1986 |
1 trial(s) available for theophylline and clofibrate
Article | Year |
---|---|
[Lipid-lowering effect of etofibrate, bezafibrate and xanthinol nicotinate in patients with hyperlipoproteinemias].
Topics: Bezafibrate; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cholesterol, VLDL; Clofibrate; Clofibric Acid; Female; Humans; Hyperlipoproteinemias; Hypolipidemic Agents; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins, VLDL; Male; Middle Aged; Theophylline; Xanthinol Niacinate | 1982 |
19 other study(ies) available for theophylline and clofibrate
Article | Year |
---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Effect of oral clofibrate administration on intestinal 3-O-methyl glucose absorption in rat and chick.
Topics: Animals; Blood Glucose; Bucladesine; Chickens; Cholesterol; Clofibrate; In Vitro Techniques; Insulin; Intestinal Absorption; Male; Methylglucosides; Methylglycosides; Rats; Theophylline; Time Factors; Triglycerides | 1978 |
[Comparative studies on the effect of commercial lipid-lowering substances on the lipolysis of isolated rat and human fat cells].
Topics: Adipose Tissue; Animals; Clofibrate; Humans; Insulin; Isoproterenol; Nicotinic Acids; Rats; Theophylline | 1978 |
Effect of gemfibrozil in vitro on fat-mobilizing lipolysis in human adipose tissue.
Topics: Adipose Tissue; Clofibrate; Depression, Chemical; Humans; Hypolipidemic Agents; In Vitro Techniques; Isoproterenol; Lipid Metabolism; Lipid Mobilization; Norepinephrine; Theophylline; Valerates; Xylenes | 1976 |
Potential antilipolytic activity of suloctidil.
Topics: Adipose Tissue; Animals; Clofibrate; Epididymis; Fatty Acids, Nonesterified; In Vitro Techniques; Male; Nicotinic Acids; Norepinephrine; Propanolamines; Propranolol; Rats; Theophylline | 1975 |
7-Substituted theophyllines. Part VI--N-[2-(4-chlorophenoxy)-1-phenyl-alkyl]-alkylamido derivatives.
Topics: Animals; Anticholesteremic Agents; Blood Coagulation; Chemical Phenomena; Chemistry; Clofibrate; Diuresis; In Vitro Techniques; Male; Platelet Aggregation Inhibitors; Rats; Rats, Inbred Strains; Theophylline; Triglycerides | 1990 |
The use of single sample clearance estimates to probe hepatic drug metabolism in rats. II.
Topics: Animals; Antipyrine; Benzoflavones; beta-Naphthoflavone; Clofibrate; Drug Interactions; Liver; Male; Metabolic Clearance Rate; Pharmaceutical Preparations; Phenobarbital; Rats; Rats, Inbred Strains; Safrole; Theophylline; Valproic Acid; Warfarin | 1988 |
Effects of clofibrate on water permeability and short-cicuit current of toad urinary bladder.
Topics: Animals; Biological Transport; Bufo marinus; Carbamazepine; Clofibrate; Cyclic AMP; In Vitro Techniques; Osmosis; Permeability; Sodium; Theophylline; Time Factors; Urinary Bladder; Vasopressins; Water | 1980 |
Favourable effect of combined Miscleron-Xavin treatment on HDL-cholesterol level.
Topics: Cholesterol, HDL; Cholesterol, LDL; Clofibrate; Drug Therapy, Combination; Humans; Hyperlipoproteinemias; Theophylline; Triglycerides; Xanthinol Niacinate | 1983 |
Xanthone analogues of clofibrate / Synthesis and biological evaluation as antagonists of lipolysis in vitro.
Topics: Adipose Tissue; Animals; Cells, Cultured; Clofibrate; Epinephrine; Lipolysis; Male; Rats; Rats, Inbred Strains; Theophylline | 1982 |